In vivo treatments with fulvestrant and anastrozole differentially affect gene expression in the rat efferent ductules

Biology of Reproduction

Volumn 84, Issue 1, 2011, Pages 52-61

  Gomes, Gisele Renata Oliveira ^a   Yasuhara, Fabiana ^a   Siu, Erica Rosanna ^a   Fernandes, Sheilla Alessandra Ferreira ^a   Avellar, Maria Christina Werneck ^a   Lazari, Maria Fatima Magalhaes ^a   Porto, Catarina Segreti ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Estradiol receptor; Gene regulation; Male reproductive tract

Indexed keywords

ANASTROZOLE; FULVESTRANT; MATRILYSIN; METHIONINE; OSTEOPONTIN; PENTRAXIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN NPTX1; SULFUR 35; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; EFFERENT DUCTULE; EPITHELIUM CELL; GENE EXPRESSION; IN VIVO STUDY; MALE; MALE GENITAL SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; EJACULATORY DUCTS; ESTRADIOL; GENE EXPRESSION REGULATION; MALE; NITRILES; RATS; RATS, WISTAR; SP1 TRANSCRIPTION FACTOR; TESTOSTERONE; TRANSCRIPTION FACTOR AP-1; TRIAZOLES;

RATTUS;

EID: 78651492367     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.085340     Document Type: Article

References (90)

1. Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS, Lubahn DB. A role for oestrogens in the male reproductive system. Nature 1997; 390: 509-512.
2. Nitta H, Bunick D, Hess RA, Janulis L, Newton SC, Millette CF, Osawa Y, Shizuta Y, Toda K, Bahr JM. Germ cells of the mouse testis express P450 aromatase. Endocrinology 1993; 132:1396-1401.
3. Janulis L, Hess RA, Bunick D, Nitta H, Janssen S, Asawa Y, Bahr JM. Mouse epididymal sperm contain active P450 aromatase which decreases as sperm traverse the epididymis. J Androl 1996; 17:111-116.
4. Janulis L, Bahr JM, Hess RA, Bunick D. P450 aromatase messenger ribonucleic acid expression in male rat germ cells: Detection by reverse transcription-polymerase chain reaction amplification. J Androl 1996; 17: 651-658.
5. Carpino A, Romeo F, Rago V. Aromatase immunolocalization in human ductuli efferentes and proximal ductus epididymis. J Anat 2004; 204:217-220.
6. Shayu D, Rao AJ. Expression of functional aromatase in the epididymis: Role of androgens and LH in modulation of expression and activity. Mol Cell Endocrinol 2006; 249:40-50.
7. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001; 81:1535-1565.
8. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson JA. Estrogen receptors: How do they signal and what are their targets. Physiol Rev 2007; 87:905-931.
9. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 1999; 13:1672-1685.
10. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 2001; 62:231-252.
11. Björnström L, Sjöberg M. Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005; 19:833-842.
12. Safe S, Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 2008; 41:263-275.
13. Wu F, Ivanov I, Xu R, Safe S. Role of SP transcription factors in hormonedependent modulation of genes in MCF-7 breast cancer cells: Microarray and RNA interference studies. J Mol Endocrinol 2009; 42:19-33.
14. Filardo EJ, Thomas P. GPR30: A seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 2005; 16: 362-367.
15. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307:1625-1630.
16. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008; 70:165-190.
17. Prossnitz ER, Sklar LA, Oprea TI, Arterburn JB. GPR30: A novel therapeutic target in estrogen-related disease. Trends Pharmacol Sci 2008; 29:116-123.
18. Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009; 20:477-482.
19. Levin ER. Membrane oestrogen receptor alpha signalling to cell functions. J Physiol 2009; 587:5019-5023.
20. Hess RA, Gist DH, Bunick D, Lubahn DB, Farrell A, Bahr J, Cooke PS, Greene GL. Estrogen receptor (alpha and beta) expression in the excurrent ducts of the adult male rat reproductive tract. J Androl 1997; 18:602-611.
21. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 1993; 90:11162-11166.
22. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB, Korach KS. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 1996; 137:4796-4805.
23. Hess RA, Bunick D, Lubahn DB, Zhou Q, Bouma J. Morphologic changes in efferent ductules and epididymis in estrogen receptor-alpha knockout mice. J Androl 2000; 21:107-121.
24. Lee KH, Hess RA, Bahr JM, Lubahn DB, Taylor J, Bunick D. Estrogen receptor alpha has a functional role in the mouse rete testis and efferent ductules. Biol Reprod 2000; 63:1873-1880.
25. Nakai M, Bouma J, Nie R, Zhou Q, Carnes K, Lubahn DB, Hess RA. Morphological analysis of endocytosis in efferent ductules of estrogen receptor-alpha knockout male mouse. Anat Rec 2001; 263:10-18.
26. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998; 95:15677-15682.
27. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127:4277-4291.
28. Shughrue PJ, Askew GR, Dellovade TL, Merchenthaler I. Estrogenbinding sites and their functional capacity in estrogen receptor double knockout mouse brain. Endocrinology 2002; 143:1643-1650.
29. Antal MC, Krust A, Chambon P, Mark M. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbetanull mutant. Proc Natl Acad Sci U S A 2008; 105:2433-2438.
30. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A 1998; 5:6965-6970.
31. Oliveira CA, Carnes K, França LR, Hess RA. Infertility and testicular atrophy in the antiestrogen-treated adult male rat. Biol Reprod 2001; 65: 913-920.
32. Oliveira CA, Zhou Q, Carnes K, Nie R, Kuehl DE, Jackson GL, Franca LR, Nakai M, Hess RA. ER function in the adult male rat: Short- and longterm effects of the antiestrogen ICI 182,780 on the testis and efferent ductules, without changes in testosterone. Endocrinology 2002; 143:2399-2409.
33. Cho HW, Nie R, Carnes K, Zhou Q, Sharief NA, Hess RA. The antiestrogen ICI 182,780 induces early effects on the adult male mouse reproductive tract and long-term decreased fertility without testicular atrophy. Reprod Biol Endocrinol 2003; 1:57.
34. Yasuhara F, Gomes GR, Siu ER, Suenaga CI, Maróstica E, Porto CS, Lazari MF. Effects of the antiestrogen fulvestrant (ICI 182,780) on gene expression of the rat efferent ductules. Biol Reprod 2008; 79:432-441.
35. Dukes M, Edwards PN, Large M, Smith IK, Boyle T. The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)-a potent, selective aromatase inhibitor. J Steroid Biochem Mol Biol 1996; 58:439-445.
36. Pearl CA, At-Taras E, Berger T, Roser JF. Reduced endogenous estrogen delays epididymal development but has no effect on efferent duct morphology in boars. Reproduction 2007; 134:593-604.
37. Matthews J, Gustafsson JA. Estrogen signaling: A subtle balance between ER alpha and ER beta. Mol Interv 2003; 3:281-292.
38. Smith CL, O'Malley BW. Coregulator function: A key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004; 25: 45-71.
39. Lewis JS, Jordan VC. Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance. Mutat Res 2005; 591:247-263.
40. McDonnell DP. The molecular pharmacology of estrogen receptor modulators: Implications for the treatment of breast cancer. Clin Cancer Res 2005; 11:871s-877s.
41. Howell A. Pure oestrogen antagonists for the treatment of advanced breast cancer. Endocr Relat Cancer 2006; 13:689-706.
42. Pike AC. Lessons learnt from structural studies of the oestrogen receptor. Best Pract Res Clin Endocrinol Metab 2006; 20:1-14.
43. Oliveira CA, Nie R, Carnes K, Franca LR, Prins GS, Saunders PT, Hess RA. The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductules. Reprod Biol Endocrinol 2003; 1:75.
44. Preisler-Mashek MT, Solodin N, Stark BL, Tyriver MK, Alarid ET. Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha. Am J Physiol Endocrinol Metab 2002; 282:E891-E898.
45. Marsaud V, Gougelet A, Maillard S, Renoir JM. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Mol Endocrinol 2003; 17:2013-2027.
46. Fan M, Bigsby RM, Nephew KP. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalphapositive breast cancer cells. Mol Endocrinol 2003; 17:356-365.
47. Long X, Nephew KP. Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptoralpha. J Biol Chem 2006; 281:9607-9615.
48. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW. Proteasomedependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A 1999; 96:1858-1862.
49. Lonard DM, Nawaz Z, Smith CL, O'Malley BW. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell 2000; 5:939-948.
50. Wijayaratne AL, McDonnell DP. The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 2001; 276:35684-35692.
51. Laïos I, Journé F, Nonclercq D, Vidal DS, Toillon RA, Laurent G, Leclercq G. Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells. J Steroid Biochem Mol Biol 2005; 94:347-359.
52. Van Den Bemd GJ, Kuiper GG, Pols HA, Van Leeuwen JP. Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. Biochem Biophys Res Commun 1999; 261:1-5.
53. Peekhaus NT, Chang T, Hayes EC, Wilkinson HA, Mitra SW, Schaeffer JM, Rohrer SP. Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line MCF-7. J Mol Endocrinol 2004; 32:987-995.
54. Prossnitz ER, Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 2009; 308:32-38.
55. Prossnitz ER, Arterburn JB, Sklar LA. GPR30: A G protein-coupled receptor for estrogen. Mol Cell Endocrinol 2007; 265-266:138-142.
56. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000; 14: 1649-1660.
57. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: A novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 2002; 80:231-238.
58. Wang MM, Traystman RJ, Hurn PD, Liu T. Non-classical regulation of estrogen receptor-alpha by ICI182,780. J Steroid Biochem Mol Biol 2004; 92:51-62.
59. Rudolph-Owen LA, Cannon P, Matrisian LM. Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. Mol Biol Cell 1998; 9:421-435.
60. Riccioli A, Dal Secco V, De Cesaris P, Starace D, Gandini L, Lenzi A, Dondero F, Padula F, Filippini A, Ziparo E. Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen. Hum Reprod 2005; 20:2814-2820.
61. Helvering LM, Adrian MD, Geiser AG, Estrem ST, Wei T, Huang S, Chen P, Dow ER, Calley JN, Dodge JA, Grese TA, Jones SA, et al. Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus. Biol Reprod 2005; 72: 830-841.
62. Cox DA, Helvering LM. Extracellular matrix integrity: A possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens? Mol Cell Endocrinol 2006; 247:53-59.
63. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
64. Cardoso LC, Nascimento AR, Royer C, Porto CS, Lazari MF. Locally produced relaxin may affect testis and vas deferens function in rats. Reproduction 2010; 139:185-196.
65. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365-386.
66. Picarelli ZP, Hyppolito N, Valle JR. Synergistic effect of 5-hydroxytryptamine on the response of rats's seminal vesicles to adrenaline and noradrenaline. Arch Int Pharmacodyn Ther 1962; 138:354-363.
67. Brooks DE. Secretion of proteins and glycoproteins by the rat epididymis: Regional differences, androgen-dependence, and effects of protease inhibitors, procaine, and tunicamycin. Biol Reprod 1981; 25:1099-1117.
68. Vreeburg JT, Holland MK, Orgebin-Crist MC. Binding of epididymal proteins to rat spermatozoa in vivo. Biol Reprod 1992; 47:588-597.
69. Avellar MC, Siu ER, Yasuhara F, Maróstica E, Porto CS. Muscarinic acetylcholine receptor subtypes in the male reproductive tract: Expression and function in rat efferent ductules and epididymis. J Mol Neurosci 2010; 40:127-134.
70. Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. In: Baxevanis AD (ed.), Current Protocols in Bioinformatics. New York: J. Wiley and Sons; 2003.
71. Borges MO, Abreu ML, Porto CS, Avellar MC. Characterization of muscarinic acetylcholine receptor in rat Sertoli cells. Endocrinology 2001; 142:4701-4710.
72. Avellar MC, Gregory CW, Power SG, French FS. Androgen-dependent protein interactions within an intron 1 regulatory region of the 20-kDa protein gene. J Biol Chem 1997; 272:17623-17631.
73. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-254.
74. Toda K, Okada T, Hayashi Y, Saibara T. Preserved tissue structure of efferent ductules in aromatase-deficient mice. J Endocrinol 2008; 199: 137-146.
75. Berton A, Selvais C, Lemoine P, Henriet P, Courtoy PJ, Marbaix E, Emonard H. Binding of matrilysin-1 to human epithelial cells promotes its activity. Cell Mol Life Sci 2007; 64:610-620.
76. Lazari MF, Lucas TF, Yasuhara F, Gomes GR, Siu ER, Royer C, Fernandes SA, Porto CS. Estrogen receptors and function in the male reproductive system. Arq Bras Endocrinol Metabol 2009; 53:923-933.
77. Oliveira CA, Mahecha GA, Carnes K, Prins GS, Saunders PT, França LR, Hess RA. Differential hormonal regulation of estrogen receptors ERalpha and ERbeta and androgen receptor expression in rat efferent ductules. Reproduction 2004; 128:73-86.
78. Bentrem D, Dardes R, Liu H, MacGregor-Schafer J, Zapf J, Jordan V. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen. Endocrinology 2001; 142:838-846.
79. Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, Chen X, Li L, Wu S, Chen Y, Jiang H, Tan L, et al. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 2008; 40:426-436.
80. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002; 1:304-313.
81. Mizukami Y. In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: From discovery to functions in vivo. Endocr J 2010; 57:101-107.
82. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270:1491-1494.
83. Smith CL. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 1998; 58:627-632.
84. Weihua Z, Lathe R, Warner M, Gustafsson JA. An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci U S A 2002; 99:13589-13594.
85. McCarthy TL, Hochberg RB, Labaree DC, Centrella M. 3-ketosteroid reductase activity and expression by fetal rat osteoblasts. J Biol Chem 2007; 282:34003-34012.
86. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006; 231:20-27.
87. Harrell PC, McCawley LJ, Fingleton B, McIntyre JO, Matrisian LM. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Exp Cell Res 2005; 303:308-320.
88. Higashiyama S, Iwabuki H, Morimoto C, Hieda M, Inoue H, Matsushita N. Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands. Cancer Sci 2008; 99:214-220.
89. Fingleton B, Powell WC, Crawford HC, Couchman JR, Matrisian LM. A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo. Hybridoma (Larchmt) 2007; 26:22-27.
90. Itoh N, Patel U, Skinner MK. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells. Endocrinology 1998; 139:1369-1377.